ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals known as phytochemicals , chemistry and analytical testing services, and product regulatory and safety consulting known as Spherix Consulting . As a result of our relationships with leading universities and research institutions, we are able to discover and license early stage, IP backed ingredient technologies. We then utilize our in house chemistry, regulatory and safety consulting business units to develop commercially viable ingredients. Our ingredient portfolio is backed with clinical and scientific research, as well as extensive IP protection. Our portfolio of patented ingredient technologies includes NIAGEN nicotinamide riboside pTeroPure pterostilbene PURENERGY, a caffeine pTeroPure co crystal ProC G, a natural black rice containing cyanidin glucoside IMMULINA , a spirulina extract and Suntava Purple Corn derived from a proprietary non GMO purple corn hybrid which contains an extraordinarily high level of anthocyanins. To learn more about ChromaDex, please visit www.ChromaDex.com.
Quote | ChromaDex Corporation (NASDAQ:CDXC)
|Last Trade Date Time:||06/09/2023 03:00:00 am|
News | ChromaDex Corporation (NASDAQ:CDXC)
ChromaDex Corp. (NASDAQ:CDXC) today announced that it will be participating at the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private 1:1 ...
2023-05-11 18:12:08 ET ChromaDex Corporation (CDXC) Q1 2023 Results Conference Call May 10, 2023 04:30 PM ET Company Participants Kendall Knysch - Director, Media Relations Rob Fried - Chief Executive Officer Brianna Gerber - Chief Financial Officer Andrew Sh...
Message Board Posts | ChromaDex Corporation (NASDAQ:CDXC)
|whytestocks: $CDXC News Article - ChromaDex to Report First Quarter 2023 Financial Results on Wednes||whytestocks||investorshangout||05/02/2023 7:55:52 PM|
|whytestocks: $CDXC News Article - ChromaDex to Report Fourth Quarter and Fiscal Year 2022 Financial||whytestocks||investorshangout||02/27/2023 1:50:47 PM|
|https://healthnews.com/longevity/longevity-supplements/can-nmn-supplements-cause||oilin07||investorshub||02/25/2023 1:33:55 PM|
|whytestocks: $CDXC News Article - ChromaDex Announces Issuance of New U.S. Patent on Dihydronicotina||whytestocks||investorshangout||02/22/2023 6:20:47 PM|
|Article on Google trending news indicated that this||tat4tat||investorshub||11/16/2022 1:41:19 AM|
ChromaDex Corporation Company Name:
CDXC Stock Symbol:
ChromaDex Corporation Website:
News, Short Squeeze, Breakout and More Instantly...